Tag: Motor Neurone Disease
-
New M102 Drug Could Substantially Slow Motor Neurone Disease Progression, Scientists Say
Overview: A potential breakthrough in motor neurone disease research In a development that could reshape the outlook for people living with motor neurone disease (MND), scientists report that a novel drug, M102, has shown promise in substantially slowing the disease’s progression. While still in the preclinical stage, the findings suggest that M102 works by safeguarding…
-
Drug breakthrough could substantially slow progression of motor neurone disease, say scientists
promising new hope for motor neurone disease researchers A new drug candidate, M102, has emerged in early-stage research as a potential way to substantially slow the progression of motor neurone disease (MND). While the findings are still in the preclinical stage, scientists say the drug’s mechanism — protecting nerve cells damaged by MND — offers…
-
New drug M102 could slow progression of motor neurone disease, say scientists
Promising MND breakthrough centers on M102 A new drug, tentatively named M102, is generating cautious optimism among researchers and patient advocates after preclinical studies suggested it could substantially slow the progression of motor neurone disease (MND). While early results are not a guarantee of clinical success, the development signals a potential shift in how MND…
-
BioBank Ireland: A Nationwide Health Snapshot Through Biobanking
BioBank Ireland Begins a New Chapter in Population Health Plans have been unveiled to create a comprehensive snapshot of the health of people living on the island of Ireland by combining genetic information with lifestyle, environmental, biomarker, and healthcare outcome data. Led by BioBank Ireland, the initiative aims to transform how researchers understand disease and…
-
BioBank Ireland Health Snapshot: Genomic Insight for Ireland
Overview: Building a health snapshot for Ireland BioBank Ireland has announced a bold plan to create a comprehensive snapshot of the health of people living on the island of Ireland. By combining genetic information with lifestyle, environmental factors, biomarker data, and healthcare outcomes, the initiative seeks to deepen our understanding of disease and speed up…
-
Lewis Moody reveals motor neurone disease diagnosis: rugby icon faces MND with courage
Former England captain Lewis Moody announces MND diagnosis Former England rugby captain Lewis Moody has publicly revealed he has been diagnosed with motor neurone disease (MND), also known as ALS. The 47-year-old, celebrated for his role in England’s 2003 Rugby World Cup triumph with Leicester Tigers, shared the news on social media, describing the diagnosis…
-
Lewis Moody reveals ALS diagnosis: Rugby World Cup winner faces motor neurone disease with resolve
Former England captain Lewis Moody announces ALS diagnosis Former England rugby captain Lewis Moody has revealed that he has been diagnosed with motor neurone disease (ALS). The 47-year-old, who helped England secure the 2003 Rugby World Cup and enjoyed a storied club career with Leicester Tigers, disclosed the news on X, emphasizing that he plans…
-
Lewis Moody Diagnosed With Motor Neurone Disease: Rugby World Cup Legend Faces ALS Battle
Former England captain Lewis Moody reveals motor neurone disease diagnosis Former England rugby captain Lewis Moody has disclosed a diagnosis of motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS). The 47-year-old, renowned for his role in England’s 2003 Rugby World Cup triumph and a long, successful career with Leicester Tigers, announced the…
-
Altnagelvin Pioneers Genetic Treatment for Motor Neurone Disease
Introduction In a groundbreaking development, Altnagelvin Hospital has made history by becoming the first Health and Social Care (HSC) Trust in Northern Ireland to provide a genetic treatment for Motor Neurone Disease (MND). This revolutionary advancement comes through the introduction of Tofersen, a drug that has garnered attention for its potential to change the lives…
-
Altnagelvin Leads the Way with Genetic Treatment for MND
Altnagelvin Hospital Pioneers Genetic Treatment for MND The Western Health and Social Care Trust has made a significant breakthrough by becoming the first Health and Social Care (HSC) Trust in Northern Ireland to provide a genetic treatment for Motor Neurone Disease (MND). This innovative therapy, known as Tofersen, marks a pivotal moment in the fight…